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Abstract: Four new briarane diterpenoids, junceellolides M–P (1–4), were isolated 
together with seven known analogs (5–11) from the South China Sea gorgonian,  
Junceella gemmacea. The structures of these compounds were elucidated by detailed 
spectroscopic analysis and comparison with the reported data. The absolute configuration 
of compounds 1–3 were determined based on an ECD experiment, while the absolute 
configuration of compound 4 was genetically determined. All the compounds were isolated 
for the first time from J. gemmacea. These compounds showed no growth inhibitory 
activity against A549, MG63 and SMMC-7721 cell lines in an in vitro bioassay. 
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1. Introduction 
Gorgonian corals of the genus Junceella (phylum, Cnidaria; class, Anthozoa; order, Gorgonacea; 
family, Ellisellidae) are widely distributed in the subtropical and tropical waters of the Indo-Pacific 
Ocean as whip-shaped unbranched colonies of variable colors. These animals are well-known as a 
source of highly oxidized diterpenes of the briarane class [1,2]. Briarane-related natural products are 
characterized by the presence of a γ-lactone fused to a bicyclo[8.4.0] ring system [3] and have attracted 
great attention due to their chemical diversity and wide spectrum of bioactivities, including  
cytotoxic [4], anti-inflammatory [5], antibacterial [6], immunomodulatory [7], anti-fouling [8] and 
insecticidal [9] effects. Chemical investigation on the genus of Junceella can be traced back to 1983, at 
which time the isolation of junceellin [10] was reported from the Chinese gorgonian  
Junceella squamata [1]. Since then, more than 140 briarane diterpenes have been isolated from 
members of this genus, which involves four species, namely J. juncea, J. fragilis, J. gemmacea and  
J. squamata [1,11]. Previous research activities have been focused on J. juncea and J. fragilis, and 
only a few reports have dealt with corals belonging to the species J. gemmacea and J. squamata [2]. 
In our ongoing search for novel and bioactive secondary metabolites from marine invertebrates of 
the South China Sea, we were attracted by the potential medicinal value of the briarane diterpenoids. 
Previously, we reported the isolation of a series of briarane-type diterpenes with antimicrobial and 
tumor cell growth inhibition activities from the gorgonian, Dichotella gemmacea [12–15]. These 
results inspired us to continue to examine this class of metabolites, leading to the present investigation 
of the gorgonian J. gemmacea which was previously reported to be a rich source of briarane 
diterpenes. Chemical investigation on the acetone extract of these animals resulted in the isolation of 
four new briarane diterpenes, junceellolides M–P (1–4), together with seven known ones, namely 
junceellolide A (5), junceellin A (6), praelolide (7), juncin ZI (8), junceellolide B (9), junceellolide C 
(10) and junceellolide D (11) (Figure 1). The structures of these compounds were elucidated by 
extensive spectroscopic analysis (
1
H and 
13
C NMR, DEPT, HSQC, HMBC, NOESY, 
1
H–1H COSY 
and HRESIMS) and comparison with the reported analytical data for the known compounds. We 
herein report the isolation, structural determination and bioactivities of these new compounds. 
2. Results and Discussion 
Colonies of the gorgonian coral J. gemmacea (Valenciennes) were immediately frozen after 
collection and stored at −20 °C until extraction. The frozen organism was cut into small pieces and 
extracted exhaustively with acetone and methanol at room temperature. The Et2O-soluble portion  
(13.0 g) of the acetone extract was chromatographed repeatedly over silica gel, Sephadex LH-20, and 
semi-preparative RP-HPLC, to afford compounds 1–11. By extensive spectroscopic analysis combined 
with careful comparison with the reported data, the structures of the known compounds were 
determined as junceellolide A (5) [16], junceellin A (6) [1,10], praelolide (7) [16], juncin ZI (8) [17], 
junceellolide B (9) [16], junceellolide C (10) [16] and junceellolide D (11) [16]. Junceellin A (6) and 
juncin ZI (8) were once reported from J. squamata and J. juncea, respectively, and their structures 
were elucidated on the basis of ESIMS, UV, IR and NMR techniques. The structures of junceellolides 
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A–D (5, 9–11) and praelolide (7), previously obtained from the South China Sea gorgonian, J. fragilis, 
were also established by extensive spectroscopic analysis. 
Figure 1. Structures of compounds 1–11. 
 
Junceellolide M (1) was isolated as a white amorphous powder and had a molecular formula of 
C28H36O12 deduced from HRESIMS, indicating eleven degrees of unsaturation. The IR spectrum of 1 
showed absorption bands for γ-lactone (1781 cm−1) and ester carbonyl (1736 cm−1) groups. This 
observation was consistent with the signals in the 
13
C NMR and DEPT spectra (Table 1) for nine sp
2
 
carbon atoms (5 × OC=O, CH=CH, CH=C) at lower field and nineteen sp
3
 carbon atoms at higher field 
(1 × C, 2 × CH, 2 × CH2, 6 × CH3, 2 × OC, 4 × OCH, 2 × OCH2), accounting for seven double-bond 
equivalents. The remaining double bond equivalents were due to the presence of three rings in  
the molecule. 
The NMR data for compound 1 were almost identical to those of frajunolide D (12) [18], an 
analogue isolated from the gorgonian J. fragilis, except for the absence of one acetate ester group. 
Location of the missing acetate ester group to C-12 was indicated by the distinct correlations from  
H2-12 to H2-13 and to H-14 in a 
1
H–1H COSY experiment of 1 (Figure 2). The planar structure of 1 
was further supported by 
1
H–1H COSY and HMBC data, as shown in Figure 2. 
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Table 1. 
1
H NMR data of compounds 1–4 (in CDCl3, J in Hz). s = singlet; d = doublet;  
t = triplet; m = multiplet; br s = broad singlet; br d = broad doublet; dd = doublet of 
doublets; tt = triplet of triplets; ov = overlapped signals. 
Position 1 
a
 2 
b
 3 
a
 4 
a
 
2 5.61 ov 5.52 d (9.5) 5.60 ov 5.61 ov 
3 5.59 ov 5.61 dd (9.5, 10.5)  5.59 ov 6.16 dd (16.9, 5.7) 
4 6.26 d (9.1) 6.33 d (10.5) 6.26 d (9.1) 6.41 d (16.9) 
6 5.76 d (8.6) 6.01 d (9.0) 5.87 d (8.3) 5.62 ov 
7 4.97 d (8.6) 4.95 dd (9.0, 1.5) 4.98 d (8.3) 5.69 br s 
9 4.75 ov 4.75 d (5.5) 4.74 d (5.0) 5.94 d (5.7) 
10 3.12 d (5.1) 3.10 d (5.5) 3.13 d (5.0) 3.28 d (5.7) 
12α 2.20 ov 2.20 ov 2.20 ov 2.22 ov 
12β 1.10 ov 1.10 ov 1.10 ov 2.25 ov 
13β 1.73 m 1.73 m 1.72 ov 1.78 ov 
13α 1.96 ov 1.94 ov 1.93 ov 1.95 ov 
14 4.90 br s 4.89 br s 4.88 br s 4.88 br s 
15-Me 1.00 s 1.01 s 1.00 s 0.90 s 
16a 5.31 d (16.0) 4.62 d (13.0) 4.43 d (14.6) 4.16 ov 
16b 4.72 d (16.0) 4.56 d (13.0) 4.27 d (14.6) 4.17 ov 
17 2.27 q (7.0) 2.27 q (6.7) 2.26 q (7.0) 2.64 q (7.2) 
18-Me 1.14 d (7.0) 1.13 d (6.7) 1.14 d (7.0) 1.25 d (7.2) 
20a 3.50 br s 3.50 br s 3.51 br s 5.11 s 
20b 2.65 d (2.5) 2.65 d (1.5) 2.64 d (2.2) 5.16 s 
-OAc 2.18 s 2.18 s 2.18 s 2.25 s 
 2.14 s 2.04 s 2.08 s 2.19 s 
 2.09 s 1.99 s 1.98 s 2.10 s 
 1.97 s    
-OH 2.85 d (1.7) 2.83 d (1.5)   
OMe   3.43 s (3H)  
a Spectra recorded at 400 MHz; b spectra recorded at 500 MHz. 
Figure 2. Key HMBC (arrow H→C) and 1H–1H COSY (bond) correlations for  
compound 1. 
 
Mar. Drugs 2014, 12 593 
 
 
The relative configuration of 1 was proven to be the same as that of frajunolide D (12) by a NOESY 
experiment (Figure 3), in which we have arbitrarily chosen the β-orientation of H-13β, H-14,  
Me-15, H-17 and H2-20 and an α-orientation of H-2, H-9, H-10, Me-18 and 8-OH. The geometry of 
the Δ3 double bond was assigned as Z based on the proton coupling constant between H-3 and H-4  
(J = 8.7 Hz), while the geometry of the Δ5 double bond was E as deduced from an NOE correlation 
between H-6 and H-16a. The chemical shift value of C-11 and C-20 (δC 60.1 and 50.5, respectively) 
supported the α-configurational assignment of the 11,20-epoxy group. It has been reported that the 13C 
NMR shifts for C-11 and C-20 are at δ 62–63 and 58–60 when the epoxy group is β-oriented and at  
δ 55–61 and 47–52 ppm when α-oriented [19]. The relative configuration of 1 was thus determined as 
(1R*,2S*,3Z,5E,7S*,8S*,9S*,10S*,11R*,14S*,17R*). 
Figure 3. Key NOESY correlations for compound 1. 
 
Because compound 1 contained the same lactone and diene chromophores as gemmacolide N  
(13) [14], and because they differed only in the nature of the ester group at the C-12 and C-16 
positions, the ECD spectrum of gemmacolide N could be used as an ECD reference for the 
configurational assignment of junceellolide M. Based on a negative ECD transition in the region  
250–200 nm and a positive band below 200 nm, the absolute configuration of 1 was determined as  
(–)-(1R,2S,3Z,5E,7S,8S,9S,10S,11R,14S,17R) (Figure 4).  
Figure 4. The ECD spectra of compounds 1–3 in acetonitrile. 
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Junceellolide N (2) was obtained as a white powder. The molecular formula was determined to be 
C26H33O10Cl by HRESIMS. An isotopic ratio of 3:1 was observed in the molecular ion peaks at m/z 
563.1663/565.1782 [M + Na]
+
, further indicating the presence of one chlorine atom. The comparison 
of the overall 
1
H and 
13
C NMR data of 2 with those of 1 (Table 1) revealed a close similarity, except 
that the acetyl group at C-16 in 1 was replaced by a chlorine atom in 2. The structure was fully 
supported by the 2D NMR experiments, including 
1
H–1H COSY, HMBC and NOESY. Compound 2 
also gave a similar negative ECD band at 202 nm and a positive one below 200 nm (Figure 4), and 
thus its absolute configuration was then determined as (−)-(1S,2S,3Z,5E,7S,8S,9S,10S,11R,14S,17R). 
Junceellolide O (3) had a molecular formula of C27H36O11, as deduced from the HRESIMS. The 
1
H 
and 
13
C NMR data of 3 also closely resembled those of 1, except for the replacement of the acetyl 
group at C-16 in 1 by a methoxy group (δH 3.43, δC 58.5) in 3. This assignment was further confirmed 
by the distinct HMBC correlation from H2-16 to the methoxy carbon (δC 58.5). The relative and 
absolute configuration of 3 was proven to be the same as that of 1 by analysis of the NOESY and ECD 
spectra, and was thus determined as (+)-(1S,2S,3Z,5E,7S,8S,9S,10S,11R,14S,17R).  
Junceellolide P (4) had a molecular formula of C26H33O9Cl, as determined by HRESIMS, and 
showed the presence of a chlorine atom in the molecule by the isotopic ratio of molecular ion peaks  
m/z 547.1715/549.1753 [M + Na]
+
 (3:1). Its IR spectrum indicated the presence of hydroxy 
(3497 cm
−1
), γ-lactone (1777 cm−1) and ester (1740 cm−1) functionalities. The 1H and 13C NMR spectra 
of 4 demonstrated a set of typical NMR signals for a briarane diterpenoid (Table 1), including ten sp
2
 
carbon atoms (4 × OC=O, CH=CH, CH=C, CH2=C) at lower field and sixteen sp
3
 carbon atoms at 
higher field (1 × C, 2 × CH, 2 × CH2, 5 × CH3, 1 × OC, 4 × OCH, 1 × CH2Cl).  
The gross structure of compound 4 was characterized by a detailed analysis of 2D NMR spectra. 
The 
1
H–1H COSY spectrum gave five proton spin systems of H-2/H-3/H-4, H-6/H-7, H-9/H-10,  
H2-12/H2-13/H-14 and H-17/H3-18. The connections of these proton sequences led to the 
establishment of the planar structure of 4 by the observation of distinct HMBC correlations from H3-15 
to C-1, C-2, C-10 and C-14, H2-16 to C-4 and C-5, H-6 to C-16, H-17 to C-7, C-8, C-9 and C-19, H-9 
to C-8 and H2-20 to C-10, C-11 and C-12, respectively (Figure 5). The relative configurations at chiral 
centers were proven to be the same as those of compounds 1–3. Interestingly, the large coupling 
constant for the olefinic protons (J = 16.8 Hz) indicated an E geometry of Δ3 in 4 in contrast to those 
of the Z double bonds in structures 1–3. To our knowledge, this is the first report of a trans Δ3,5 
conjugated diene in a briarane diterpenoid. The relative configuration of 4 was established by NOE 
(Figure 6) and coupling constant analysis whereas we propose its absolute configuration as 
(1R,2S,3E,5E,7S,8S,9S,10S,11R,14S,17R)-4, due to its biogenetic correlation with those of  
compounds 1–3. 
Compounds 1–11 were evaluated for their ability to inhibit tumor cell growth using the A549, 
MG63 and SMMC-7721 cell lines [20]. None of these compounds exhibited growth inhibitory effects 
against these cell lines in the in vitro bioscreening (IC50 ≥ 40 µM). 
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Figure 5. Key HMBC correlations (arrow H→C) and COSY (bond) spin coupling systems 
for compound 4. 
 
Figure 6. Key NOESY correlations of compound 4. 
 
3. Experimental Section  
3.1. General Experimental Procedures  
Commercial silica gel (Yantai, China, 200–300; 400–500 mesh) and RP silica gel (Merck, 
Darmstadt, Germany, 43–60 µm) were used for column chromatography (CC). Sephadex LH-20 (GE 
Healthcare Bio-Sciences AB, SE-751 84 Uppsala, Sweden) was used for either purification or 
separation. TLC was carried out on precoated silica gel plates (Yantai, China, HSGF-254) and RP 
silica gel (Macherey-Nagel, Düren, Germany, RP-18 F254), and spots were detected on TLC under 
UV and visualized by spraying with anisaldehyde-sulfuric acid reagent, followed by heating. HPLC 
was performed using a system comprised of an Agilent G1311A pump, an Agilent G1315B DAD 
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detector and a Rheodyne 7725 injection port. A semi-preparative normal-phase column (YMC Pack 
ODS-A, 250  10 mm I.D., particle size 5 µm, 250 × 10 mm, YMC Europe GmbH, Dinslaken, 
Germany) was used for HPLC. The NMR data were recorded on a Bruker DRX 400 and Avance 500 
spectrometers at 400 or 500 MHz for 
1
H and 100 or 125 MHz for 
13
C, respectively. Chemical shifts are 
reported in parts per million (δ), with the use of the residual CDCl3 signal (δH = 7.27 ppm) as an 
internal standard for 
1
H NMR and CDCl3 (δC = 77.02 ppm) for 
13
C NMR, and the coupling constants 
(J) were in Hz. The 
1
H and 
13
C NMR assignments were supported by 
1
H–1H COSY, HSQC, HMBC 
and NOESY experiments. The following abbreviations are used to describe spin multiplicity: s denotes 
singlet; d denotes doublet; t denotes triplet; m denotes multiplet; br s denotes broad singlet; br d 
denotes broad doublet; dd denotes doublet of doublets; tt denotes triplet of triplets; ov denotes 
overlapped signals. Optical rotations were measured in CH2Cl2 with an Autopol IV polarimeter at the 
sodium D line (590 nm). Infrared spectra were recorded in thin polymer films on a Nexus 470 FT-IR 
spectrophotometer (Nicolet, USA); peaks are reported in cm
−1
. UV absorption spectra were recorded 
on a Varian Cary 100 UV-Vis spectrophotometer; peak wavelengths are reported in nanometers. 
Circular dichroism spectra were recorded with a JASCO J-715 circular dichroism spectropolarimeter. 
The HRMS were performed on a Q-TOF micro-mass spectrometer (resolution: 5000). An isopropyl 
alcohol solution of sodium iodide (2 mg/mL) was used as a reference compound.  
3.2. Animal Material 
Specimens of the gorgonian coral Junceella gemmacea were collected from the South China Sea in 
October 2011, and identified by Xiu-Bao Li of the South China Sea Institute of Oceanology,  
Academia Sinica. The voucher specimen was deposited in the Second Military Medical University,  
Shanghai, China. 
3.3. Extraction and Isolation 
The frozn animals (2500 g, wet weight) were cut into small pieces and extracted ultrasonically for 
four times (3000 mL × 4) with acetone and MeOH at room temperature. The organic extracts were 
concentrated under vacuum to give a residue, which was suspended into H2O and extracted with 
diethyl ether and n-butanol for four times, respectively. The Et2O-soluble portion was separated on a 
Sephadex LH-20 column (CH2Cl2:MeOH 1:1) giving fractions 1–10 (Fr.1~Fr.10). Fr.6 was subjected 
to SiO2 column chromatography using solvents of increasing polarity from petroleum to acetone (TLC 
(GF 254) monitoring) to obtain eleven subfractions (P.1~P.11). P.11 was separated by reversed-phase 
silica gel chromatography (gradient MeOH/H2O, from 30:70 to 0:100), followed by semi-preparative 
RP-HPLC (MeOH/H2O, 58:42, flow rate of 2.0 mL/min), to yield compounds 1 (4.2 mg, tR 35 min) 
and 3 (3.7 mg, tR 32 min). Fr.8 was fractioned on silica gel eluting with petroleum/acetone (stepwise, 
20:1–0:1) and then chromatographed on a gravity column with ODS using MeOH/water (gradient from 
30:70 to 0:100, in 10% increments) as the eluent to afford subfractions S.10 and S.11. S.10 was 
isolated by reversed-phase silica gel chromatography (gradient elution from MeOH/H2O (30:70) to 
100% MeOH, in 10% increments) and successively subjected to RP-HPLC (MeOH/H2O 79:21,  
2 mL/min), producing 5 (2.6 mg, tR 29 min). S.11 was chromatographed over RP-silica gel column 
chromatography using a gradient of MeOH/H2O (30:70 to 0:100, in 10% increments) to yield 
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subfractions R.4 and R.5. A HPLC chromatographic isolation on R.4 (MeOH/H2O 62:38, 2 mL/min) 
led to the preparation of 2 (2.4 mg, tR 60 min), 8 (2.3 mg, tR 39 min), 10 (4.9 mg, tR 53 min) and  
11 (3.4 mg, tR 83 min). Furthermore, R.5 was further separated by HPLC using MeOH/H2O (56:44) at 
the flow rate of 2.0 mL/min and provided 4 (5.9 mg, tR 51 min) and 9 (1.6 mg, tR 54 min). Using 
petroleum/acetone (7:1) as the eluent, the crystal precipitated from Fr.8 furnished 6 (35.0 mg) and  
7 (16.9 mg) on Silica gel column chromatography. 
Junceellolide M (1): white amorphous powder; [α]25 D  = −0.85° (c 0.47, CH2Cl2); UV (MeOH)  
230 nm; CD (CH3CN, c 3.0 × 10
−4
) λmax (Δε) positive below 193.5 nm, 200 (−5.67) nm; IR (film)  
νmax 2959, 2930, 1781, 1736, 1252, 1225 cm
−1
; 
1
H NMR spectroscopic data, see Table 1; 
13
C NMR 
spectroscopic data, see Table 2; HRESIMS m/z 587.2100 [M + Na]
+
, calcd. for C28H36O12Na, 587.2104.  
Table 2. 
13
C NMR data of compounds 1–4 (in CDCl3, J in Hz). 
Position 1 
a
 2 
b
 3 
a
 4 
a
 
1 47.1, C 47.2, C 47.3, C 49.1, C 
2 74.7, CH 74.6, CH 74.8, CH 75.5, CH 
3 132.6, CH 132.3, CH 131.7, CH 137.8, CH 
4 127.2, CH 127.8, CH 128.2, CH 126.4, CH 
5 139.6, C 140.0, C 141.4, C 140.0, C 
6 122.5, CH 126.2, CH 123.0, CH 127.6, CH 
7 78.8, CH 78.6, CH 79.0, CH 80.7, CH 
8 80.9, C 80.9, C 80.9, C 80.7, C 
9 64.6, CH 64.6, CH 64.7, CH 73.4, CH 
10 37.8, CH 37.8, CH 37.8, CH 43.2, CH 
11 60.1, C 60.0, C 60.1, C 148.9, C 
12 29.2, CH2 29.2, CH2 29.3, CH2 31.2, CH2 
13 25.1, CH2 25.0, CH2 25.1, CH2 27.8, CH2 
14 74.4, CH 74.5, CH 74.7, CH 78.8, CH 
15 14.4, CH3 14.4, CH3 14.5, CH3 15.7, CH3 
16 63.0, CH2 44.9, CH2 72.4, CH2 47.5, CH2 
17 44.0, CH 44.0, CH 44.1, CH 45.4, CH 
18 6.4, CH3 6.4, CH3 6.4, CH3 8.2, CH3 
19 175.6, C 175.6, C 175.7, C 175.4, C 
20 50.5, CH2 50.5, CH2 50.5, CH2 111.4, CH2, 
-OAc 170.3, C 170.2, C 170.3, C 170.4, C 
 21.6, CH3 21.6, CH3 21.6, CH3 21.5, CH3 
 170.2, C 170.2, C 170.2, C 169.7, C 
 20.9, CH3 21.3, CH3 21.3, CH3 21.7, CH3 
 170.4, C 169.7, C 169.5, C 169.9, C 
 21.2, CH3 21.1, CH3 21.2, CH3 20.9, CH3 
 169.4, C    
 21.1, CH3    
OMe   58.5, CH3  
a Spectra recorded at 100 MHz; b spectra recorded at 125 MHz. 
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Junceellolide N (2): white amorphous powder; [α]25 D  = −10.89° (c 0.32, CH2Cl2); UV (MeOH) 418, 
231 nm; CD (CH3CN, c 3.0 × 10
−4
) λmax (Δε) positive below 192 nm, 202.5 (−3.23) nm; IR (film)  
νmax 2959, 2930, 1782, 1731, 1288, 1274 cm
−1
; 
1
H NMR spectroscopic data, see Table 1; 
13
C NMR 
spectroscopic data, see Table 2; HRESIMS m/z 563.1663 [M + Na]
+
, calcd. for  
C26H33O10ClNa, 563.1660. 
Junceellolide O (3): white amorphous powder; [α]
25 
D  = +8.75° (c 0.04, CH2Cl2); UV (MeOH)  
228 nm; CD (CH3CN, c 3.0 × 10
−4
) λmax (Δε) positive below 198 nm, 209 (−3.08) nm; IR (film)  
νmax 2959, 2930, 1780, 1732, 1272 cm
−1
; 
1
H NMR spectroscopic data, see Table 1; 
13
C NMR 
spectroscopic data, see Table 2; HRESIMS m/z 559.2158 [M + Na]
+
, calcd. for  
C27H36O11Na, 559.2155. 
Junceellolide P (4): white acicular crystal, [α]25 D  = −59.29° (c 0.28, CH2Cl2); UV (MeOH) 229 nm; 
IR (film) νmax 3456, 1777, 1740, 1236 cm
−1
; 
1
H NMR spectroscopic data, see Table 1; 
13
C NMR 
spectroscopic data, see Table 2; HRESIMS m/z 547.1715 [M + Na]
+
, calcd. for  
C26H33O9ClNa, 547.1711. 
3.4. Cytotoxicity Assay 
Compounds 1–11 were evaluated for cytotoxicity against human lung adenocarcinoma (A549), 
human osteosarcoma cell (MG63) and human hepatocellular carcinoma cell lines (SMMC-7721), 
using a modification of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) 
colorimetric method [21]. Adriamycin was used as a positive control. 
4. Conclusions  
Chemical investigation of the South China Sea gorgonian, Junceella gemmacea (Valenciennes), has 
led to the isolation of four new 3,5-dien-7,18-olide briarane-type diterpenoids, junceellolides M–P  
(1–4), along with seven previously described analogues (5–11). All the compounds were reported for 
the first time from Junceella gemmacea. The compounds were tested for growth inhibition activity 
against A549, MG63 and SMMC-7721 cell lines but were found to be inactive. 
The isolation of an array of briarane diterpenoids demonstrates the productive chemical diversity of 
the gorgonian coral J. gemmacea, similar to that found in other species of this genus as well as in the 
genus Dichotella [2,20,22] The complexity of these intriguing structures and variable potential for 
tumor cell growth inhibition activity of compounds in this structure class may attract additional 
attention from chemists and pharmacologists, and encourage further investigations on the chemistry 
and antitumor activity of this cluster of metabolites. 
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